![Jill Broadfoot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jill Broadfoot
Directeur Financier/CFO chez
ATYR PHARMA, INC.
Fortune : 27 226 $ au 31/05/2026
Profil
Jill M.
Broadfoot is currently an Independent Director at Talphera, Inc. since 2021, a Director at Angiocrine Bioscience, Inc., and Chief Financial Officer at aTyr Pharma, Inc. since 2018.
Former positions include Independent Director at Otonomy, Inc. from 2021 to 2023, Director at Cue Biopharma, Inc. from 2025 to 2026, Divisional Controller at Medical Imaging Centers of America, Inc. in 1994, Chief Financial Officer, Secretary & Senior Vice President at Vical, Inc. from 2004 to 2013, Vice President-Finance & Controller at DJO Global, Inc. in 2004, Audit Manager at Ernst & Young LLP from 1994 to 1999, Vice President & Controller at GW Pharmaceuticals Ltd. from 2016 to 2017, and Chief Financial Officer at Emerald Health Pharmaceuticals, Inc. and Emerald Health Bioceuticals, Inc. from 2017 to 2018.
Education includes an undergraduate degree from San Diego State University conferred in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ATYR PHARMA, INC. 0,04% | 01/03/2026 | 37 296 ( 0,04% ) | 20 252 $ | 31/05/2026 |
TALPHERA, INC. 0,02% | 24/04/2026 | 8 547 ( 0,02% ) | 6 974 $ | 31/05/2026 |
CUE BIOPHARMA, INC. -.--% | 05/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Jill Broadfoot
| Sociétés | Poste | Début |
|---|---|---|
| ATYR PHARMA, INC. | Directeur Financier/CFO | 30/07/2018 |
| TALPHERA, INC. | Directeur/Membre du Conseil | 20/11/2021 |
Angiocrine Bioscience, Inc.
 Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage cell and gene therapy company | Directeur/Membre du Conseil | - |
Anciens postes connus de Jill Broadfoot
| Sociétés | Poste | Fin |
|---|---|---|
| CUE BIOPHARMA, INC. | Directeur/Membre du Conseil | 29/05/2026 |
| OTONOMY | Directeur/Membre du Conseil | 15/02/2023 |
Emerald Health Bioceuticals, Inc.
 Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Provides research and development of phytocannabinoids and nutritional supplements for support of human endocannabinoid health | Directeur Financier/CFO | 01/07/2018 |
Emerald Health Pharmaceuticals, Inc.
 Emerald Health Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes medicines | Directeur Financier/CFO | 01/07/2018 |
| GW PHARMACEUTICALS PLC | Comptroller/Controller/Auditor | 01/01/2017 |
Formation de Jill Broadfoot
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Medical Imaging Centers of America, Inc.
 Medical Imaging Centers of America, Inc. Medical/Nursing ServicesHealth Services Owns and manages diagnostic imaging centers | Health Services |
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
DJO Global, Inc.
 DJO Global, Inc. Medical SpecialtiesHealth Technology Manufactures and sells orthopedic devices for physical therapy | Health Technology |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Angiocrine Bioscience, Inc.
Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage cell and gene therapy company | Commercial Services |
GW Pharmaceuticals Ltd.
 GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets novel therapeutics | Health Technology |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Talphera, Inc.
 Talphera, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurology diseases | Health Technology |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Emerald Health Pharmaceuticals, Inc.
Emerald Health Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes medicines | Health Technology |
Emerald Health Bioceuticals, Inc.
Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Provides research and development of phytocannabinoids and nutritional supplements for support of human endocannabinoid health | Health Technology |
